Cargando…
非小细胞肺癌患者K-RAS基因突变的研究
BACKGROUND AND OBJECTIVE: Recent studies indicated that Non-small cell lung cancer (NSCLC) patients with mutant K-RAS failed to benefit from adjuvant chemotherapy, and the cancer did not respond to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs). These findings indicated th...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015157/ https://www.ncbi.nlm.nih.gov/pubmed/20681447 http://dx.doi.org/10.3779/j.issn.1009-3419.2010.06.007 |